An Analysis of Boswellia serrata for Rheumatoid Arthritis Treatment
VerifiedAdded on 2023/06/11
|16
|2161
|92
Report
AI Summary
This report investigates the effectiveness of Boswellia serrata in treating rheumatoid arthritis (RA). It begins by introducing Boswellia as an anti-inflammatory agent capable of alleviating pain and preventing cartilage loss. The report outlines the aim to understand Boswellia's effectiveness and the objective to analyze the causes and impacts of RA. Methodologically, the study employs a search strategy using keywords and MeSH terms across databases like PubMed and ScienceDirect, adhering to inclusion and exclusion criteria visualized through a PRISMA flowchart. The discussion highlights the difficulties faced by individuals with RA and emphasizes Boswellia's potential to provide relief due to its anti-inflammatory and pain-killing properties. The recommendation underscores the safe usage of Boswellia, typically 300-400mg three times daily, for managing RA symptoms and suggests further research into natural medications for RA patients. The report concludes with a list of references supporting the analysis.
1 out of 16

















